recurrences in melanoma patients after sentinel node biosy and therapeutic lymph node dissection. Eur J Cancer, 2006, 42: 159-64.
2. Rutkowski P, Nowecki Zl, Żurawski Z, Dziewirski W, Nasierowska-Guttmejer A, Świtaj T, Ruka W.: Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stroma tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol., 2006, 93: 304-11,
3. Chmielik E, Bujko K, Nasierowska-Guttmejer A, Nowacki MP, Kępka L, Sopyło R, Wojnar A, Majewski P, Sygut J, Karoliński A, Huzarski T, Wandzel P.: Distal intramural spread of recital cancer after preoperative radiotherapy: The results of a multicenter randimized dinical study. Int J Radiat Oncol Biol Phys, 2006, 65:182-8.
4. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bębenek M, Kryj M: Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for recital cancer. BrJ Surg, 2006, 93:1215-23.
5. Nowecki Z, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.: Survival Analysis and Clinicopathological Factors Associated with False-Negative Sentinal Lymph Node Biosy Findings in Patients with Cutaneous Melanoma. Ann Surg Oncol 2006, 13:1655-63.
6. Słowińska M, Maj M, Czuwara-Ładygowska J, Zegadło-Mylik M, Szymańska E, Nasierowska-Guttmejer A, Rudnicka L: Trudności diagnostyczne w ocenie atypowych zmian melanocytowych. Medical and Biological Science 2005,19/1,83-86.
7. Bujko K, Michalski W, Kępka L, Nowacki MP, Nasierowska-Guttmejer A, Tokar P, Dymecki D, Pawlak M, Leśniak T, Richter P, Wojnar A, Chmielik E; The Polish Colorectal Study Group: Association between pathological response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metatsases In recital cancer: An analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys, 2007
8. Ćwikła JB, Nasierowska-Guttmejer A, Jeziorski KG, Cichocki A, Zgliczyński W, Stepień K, Seklecka N, Durlik M, Małkowski B, Wałecki J: Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland. Neuro Endocrinol Lett 2007 Dec;28(6):789-800.
9. Rutkowski P, Dębiec-Rychter M, Nowecki Z, Wożniak A, Michej W, Limon J, Siedlecki J, Jerzak vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W: Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors. Med. Sci Monit 2007 Nov;13(ll):CR515-522
10. Ćwikła JB, Mikołajczak R, Pawlak D, Buscombe JR, Nasierowska-Guttmejer A, Bator A, Maecke H, Wałecki J: Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with propen GEP NETs. J Nuci Med. 2008; 49:1060-1065,
11. Rutkowski A, Bujko K, Nowacki MP, Chmielik E, Nasierowska-Guttmejer A, Wojnar A; Polish Colorectal Study Group: Distal bowel surgical margin shorter than 1 cm after preoperative radioation for rectal cancer: is it safe? Ann Surg Oncol. 2008 Nov;15(ll):3124-31.
12. Polkowski M, Gerke W, Jarosz D, Nasierowska-Guttmejer A, Rutkowski P, Nowecki Zl, Ruka W, Reguła J, Butruk : Diagnostic field and safety of endoscopic ultrasound-guided trucut (corrected) biosy in patients with gastrin submucosal tumors: a prospective study. Endoscopy. 2009 Apr;41(4):329-34.
13. Ćwikła JB, Sankowski A, Seklecka N, Buscombe JR, Nasierowska-Guttmejer A, Jeziorski KG, Mikołajczak R, Pawlak D, Stepien K, Wałecki J: Efficacy of radionudide treatment DOTATATE Y-90 in patients with progressive metastatic gastropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study. Ann Oncol. 2009 Oct 15.
14. Radziszewski J, Kowalewska M, Jędrzejczak T, Kozlowicz-Gudzinska I, Nasierowska-Guttmejer A, Bidzinski M, Siedlecki JA: The accuracy of the sentinel lymph node koncept in early stage squamous celi vulvar carcinoma. Gynecol Oncol. 2009
Nov 16